Correlation Between Postoperative Cognitive-related Adverse Reactions and Brain Metabolomic Characteristics in Elderly Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age65+
SponsorShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

About this trial

Postoperative cognitive dysfunction (POCD) refers to the difficulties of orientation, cognition, communication, memory and abstract thinking of patients after anesthesia and surgery. And/or accompanied by the decline of the ability in social activities, such as the change of personality, social ability of language and behavior, cognitive function and life skills. POCD is a common complication of central nervous system in elderly patients after operation, with an early incidence of about 21% and a long-term incidence of about 35% . According to the current research on Alzheimer's disease (AD) and POCD in the elderly, it has been found that they have similar pathological basis and some homologous related genes. Altogether, POCD is closely related to molecular pathway neuropsychiatric diseases (such as dementia, depression and Alzheimer's disease). Researchers have come up with various hypotheses to reveal the underlying mechanisms of POCD, including neuritis, oxidative stress, autophagy disorder, synaptic dysfunction, and lack of neurotrophic support. To date, apart from evaluating with scales, CT Scan and EEG analysis, there is neither exact biomarkers for monitoring and diagnosing POCD, nor clear relationships between specific Brain Metabolomic Characteristics, EEG changes and diagnosis of POCD, so that the diagnosis of early POCD only stays in the evaluation of clinical symptoms and scales. Therefore, our study aims to provide an effective basis for early diagnosis and treatment of clinical POCD through multivariate analyses of clinical scales combined with Brain Metabolomic Characteristics, EEG analysis of patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

65 years or older .

Complete the operation in our hospital

ASA classification I-II level

Agree to participate in this research and agree to sign an informed consent form

Disqualifiers

History of preoperative psychosis and psychotropic drug use

The subject is diagnosed with AD;

Abnormal preoperative mental scale assessment

Have a history of emergency rescue during the perioperative period

Trial population

Our research is a single center, nested case-control study. Preoperatively collect the information of the elderly patients over 65 years old without undergoing craniocerebral operations, including the vital signs, the examination reports and other related data after excluding the factors that can't be included in the group. The patients' health scales and preoperative cognitive function scales were evaluated.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Collecting clinical data, EGG,Brain Metabolomic Characteristics(with Magnetic Resonance Spectroscopy), blood gas data and blood sample

    Other intervention

    Collecting clinical data(before induction of anesthesia and first day after surgery), EGG(first day after surgery),Magnetic Resonance Spectroscopy data (before induction of anesthesia and first day after surgery)blood gas data(before induction of anesthesia and first day after surgery) and blood sample (before induction of anesthesia and first day, third day and 7th day after surgery)

Treatment groups

200 Participants
are divided into 2 treatment groups
Group A: Patients in the control group were followed up without POCD postoperatively.1 intervention
Group B: Patients in the case group were followed up with POCD postoperatively.1 intervention

Trial outcomes

Primary outcomes

1

MMSE (mini-mental state examiniation)

MMSE scale score, If the MMSE assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of POCD.

Time frame
1 day after surgery
2

MMSE (mini-mental state examiniation)

MMSE scale score, If the MMSE assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of POCD.

Time frame
immediately before surgery
3

MMSE (mini-mental state examiniation)

MMSE scale score, If the MMSE assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of POCD.

Time frame
3 day after surgery
4

MMSE (mini-mental state examiniation)

MMSE scale score, If the MMSE assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of POCD.

Time frame
7 day after surgery

Secondary outcomes

1

3D-CAM

3D-CAM score

Time frame
1 day after surgery
2

Self-Rating Anxiety Scale

Self-Rating Anxiety Scale score

Time frame
immediately before surgery
3

Self-rating depression scale

Self-rating depression scale score

Time frame
immediately before surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.